ACR Expert Roundtable

Andrew Blauvelt, MD, leads a discussion with Melinda Gooderham, MD, MSc, and Neil Korman, MD, PhD

An expert roundtable discussion on guselkumab and risankizumab

Andrew Blauvelt, MD, leads a discussion with Melinda Gooderham, MD, MSc, and Neil Korman, MD, PhD

Our expert roundtable discusses patient-physician discordance and the need for tracking PROs

Our expert roundtable looks at possible clinical/demographic predictors, or biomarkers

Our expert roundtable discusses promising results from two studies on TYK2/JAK1 inhibitors

Our expert roundtable discusses the long-term efficacy and safety of the IL-23 inhibitor